Acute lung injury (ALI) and its most severe form, acute respiratory distress syndrome (ARDS), are characterised by high-protein pulmonary edema and severe hypoxaemic respiratory failure due to increased permeability of pulmonary microvascular endothelial cells (PMVEC). Alveolar epithelial cells (AEC) contribute importantly to normal alveolar function, and AEC dysfunction in ALI/ARDS is associated with worse outcomes. We hypothesized that AEC can modulate human PMVEC barrier function, and investigated the effects of AEC presence on human PMVEC barrier under septic conditions in vitro. PMVEC isolated from human lung were treated in vitro with septic stimulation (lipopolysaccharide [LPS], a mixture of clinically-relevant cytokines [cytomix], or plasma from patients with severe sepsis), and the trans-PMVEC leak of Evans Blue dye-labeled albumin assessed. PMVEC septic responses were compared in the presence/absence of co-cultured A549 epithelial cell line or primary human AEC. Septic stimulation with LPS, cytomix, or septic plasma induced marked PMVEC hyper-permeability (10.2±1.8, 8.9±2.2, and 3.7±0.2 fold-increase vs. control, respectively, p<0.01 for all). The presence of A549 cells or primary human AEC in a non-contact co-culture model attenuated septic PMVEC hyper-permeability by 39±4% to 100±3%, depending on the septic stimulation (p<0.05). Septic PMVEC hyper-permeability was also attenuated following treatment with culture medium conditioned by previous incubation with either na？ve or cytomix-treated A549 cells (p<0.05), and this protective effect of A549 cell-conditioned medium was both heat-stable and transferable following lipid extraction. Cytomix-stimulated PMN-dependent PMVEC hyper-permeability and trans-PMVEC PMN migration were also inhibited in the presence of A549 cells or A549 cell-conditioned medium (p<0.05). Human AEC appear to protect human PMVEC barrier function under septic conditions in vitro, through release of a soluble mediator(s), which are at least partly lipid in nature. This study suggests a scientific and potential clinical therapeutic importance of epithelial-endothelial cross talk in maintaining alveolar integrity in ALI/ARDS.
References
[1]
Tomashefski JF (2000) Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 21: 435–466.
[2]
Matthay MA, Zemans RL (2011) The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 6: 147–163.
[3]
Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342: 1334–1349.
[4]
Rubenfeld GD, Herridge MS (2007) Epidemiology and outcomes of acute lung injury. Chest 131: 554–562.
[5]
Razavi HM, Wang L, Weicker S, Quinlan GJ, Mumby S, et al. (2005) Pulmonary oxidant stress in murine sepsis is due to inflammatory cell nitric oxide. Crit Care Med 33: 1333–1339.
[6]
Razavi HM, Wang LF, Weicker S, Rohan M, Law C, et al. (2004) Pulmonary neutrophil infiltration in murine sepsis: role of inducible nitric oxide synthase. Am J Respir Crit Care Med 170: 227–233.
[7]
Wang LF, Patel M, Razavi HM, Weicker S, Joseph MG, et al. (2002) Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis. Am J Respir Crit Care Med 165: 1634–1639.
[8]
Bhatia M, Moochhala S (2004) Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202: 145–156.
[9]
Shelton JL, Wang L, Cepinskas G, Sandig M, Scott JA, et al. (2007) Inducible NO synthase (iNOS) in human neutrophils but not pulmonary microvascular endothelial cells (PMVEC) mediates septic protein leak in vitro. Microvasc Res 74: 23–31.
[10]
Shelton JL, Wang L, Cepinskas G, Sandig M, Inculet R, et al. (2006) Albumin leak across human pulmonary microvascular vs. umbilical vein endothelial cells under septic conditions. Microvasc Res 71: 40–47.
[11]
Farley KS, Wang LF, Razavi HM, Law C, Rohan M, et al. (2006) Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol 290: L1164–L1172.
[12]
Gorin AB, Stewart PA (1979) Differential permeability of endothelial and epithelial barriers to albumin flux. J Appl Physiol 47: 1315–1324.
[13]
Berthiaume Y, Matthay MA (2007) Alveolar edema fluid clearance and acute lung injury. Respir Physiol Neurobiol 159: 350–359.
[14]
Manicone AM (2009) Role of the pulmonary epithelium and inflammatory signals in acute lung injury. Expert Rev Clin Immunol 5: 63–75.
[15]
Thorley AJ, Ford PA, Giembycz MA, Goldstraw P, Young A, et al. (2007) Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages. J Immunol 178: 463–473.
[16]
Witherden IR, Vanden Bon EJ, Goldstraw P, Ratcliffe C, Pastorino U, et al. (2004) Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. Am J Respir Cell Mol Biol 30: 500–509.
[17]
Wang L, Bastarache JA, Wickersham N, Fang X, Matthay MA, et al. (2007) Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. Am J Respir Cell Mol Biol 36: 497–503.
[18]
Ehrhardt C, Kim KJ, Lehr CM (2005) Isolation and culture of human alveolar epithelial cells. Methods Mol Med 107: 207–216.
[19]
Hermanns MI, Fuchs S, Bock M, Wenzel K, Mayer E, et al. (2009) Primary human coculture model of alveolo-capillary unit to study mechanisms of injury to peripheral lung. Cell Tissue Res 336: 91–105.
[20]
Bone RC, Sibbald WJ, Sprung CL (1992) The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101: 1481–1483.
[21]
Schnitzer SE, Weigert A, Zhou J, Brüne B (2009) Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells. Mol Cancer Res 7: 393–401.
[22]
Singh LS, Berk M, Oates R, Zhao Z, Tan H, et al. (2007) Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer. J Natl Cancer Inst 99: 1313–1327.
[23]
Shelton JL, Wang L, Cepinskas G, Sandig M, Scott JA, et al. (2007) Inducible NO synthase (iNOS) in human neutrophils but not pulmonary microvascular endothelial cells (PMVEC) mediates septic protein leak in vitro. Microvasc Res 74: 23–31.
[24]
Moss M, Gillespie MK, Ackerson L, Moore FA, Moore EE, et al. (1996) Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome. Crit Care Med 24: 1782–1786.
[25]
Ware LB, Eisner MD, Thompson BT, Parsons PE, Matthay MA (2004) Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 170: 766–772.
[26]
Clerici C (2011) The challenge of modeling human acute respiratory distress syndrome: a new model of lung injury due to sepsis with impaired alveolar edema fluid removal. Am J Physiol Lung Cell Mol Physiol 301: L20–L22.
[27]
Shelton JL, Wang L, Cepinskas G, Inculet R, Mehta S (2008) Human neutrophil-pulmonary microvascular endothelial cell interactions in vitro: differential effects of nitric oxide vs. peroxynitrite. Microvasc Res 76: 80–88.
[28]
Burns AR, Smith CW, Walker DC (2003) Unique structural features that influence neutrophil emigration into the lung. Physiol Rev 83: 309–336.
[29]
Thorley AJ, Goldstraw P, Young A, Tetley TD (2005) Primary human alveolar type II epithelial cell CCL20 (macrophage inflammatory protein-3alpha)-induced dendritic cell migration. Am J Respir Cell Mol Biol 32: 262–267.
[30]
Mason RJ (2006) Biology of alveolar type II cells. Respirology 11 Suppl: S12–S15
[31]
Singleton PA, Dudek SM, Chiang ET, Garcia JG (2005) Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J 19: 1646–1656.
[32]
Jacobs ER, Zeldin DC (2001) The lung HETEs (and EETs) up. Am J Physiol Heart Circ Physiol 280: H1–H10.
[33]
Bastarache JA, Fremont RD, Kropski JA, Bossert FR, Ware LB (2009) Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 297: L1035–L1041.
[34]
Wright JR (2005) Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5: 58–68.
[35]
Orgeig S, Hiemstra PS, Veldhuizen EJ, Casals C, Clark HW, et al. (2010) Recent advances in alveolar biology: evolution and function of alveolar proteins. Respir Physiol Neurobiol 173 Suppl: S43–S54
[36]
Weppler A, Rowter D, Hermanns I, Kirkpatrick CJ, Issekutz AC (2006) Modulation of endotoxin-induced neutrophil transendothelial migration by alveolar epithelium in a defined bilayer model. Exp Lung Res 32: 455–482.
[37]
Breslin JW, Yuan SY (2004) Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability. Am J Physiol Heart Circ Physiol 286: H1057–H1062.
[38]
Pober JS, Min W, Bradley JR (2009) Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 4: 71–95.
[39]
Perl M, Lomas-Neira J, Venet F, Chung CS, Ayala A (2011) Pathogenesis of indirect (secondary) acute lung injury. Expert Rev Respir Med 5: 115–126.
[40]
Ochoa CD, Stevens T (2012) Studies on the cell biology of interendothelial cell gaps. Am J Physiol Lung Cell Mol Physiol 302: L275–L286.
[41]
DiStasi MR, Ley K (2009) Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol 30: 547–556.
[42]
Grommes J, Soehnlein O (2011) Contribution of neutrophils to acute lung injury. Mol Med 17: 293–307.
[43]
Wang L, Taneja R, Razavi HM, Law C, Gillis C, et al. (2012) Specific Role of Neutrophil Inducible Nitric Oxide Synthase in Murine Sepsis-Induced LungInjury in vivo. Shock 37: 539–547.
